Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England
Open Access
- 9 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (7), 1001-1011
- https://doi.org/10.1093/infdis/jiu213
Abstract
Background. The 7-valent pneumococcal conjugate (PCV7) vaccine's impact on invasive pneumococcal disease (IPD) is well described, but few reports exist on the additional impact of the 13-valent vaccine (PCV13). Methods. We calculated the IPD incidence across all ages in a surveillance project following implementation of PCV7 (in September 2006) and PCV13 (in April 2010) in children aged Results. The overall incidence decreased from 10 cases/100 000 persons per year in 1996–1997 to 8 cases/100 000 persons per year in 2007–2008 and 7 cases/100 000 in 2012–2013. Declines were greater in children aged P < .001), whereas the incidence of IPD due to the additional 6 serotypes in PCV13 and to nonvaccine types (NVTs) increased in children aged ≥2 years (P < .001 for both comparisons). The incidence of IPD due to the 6 additional serotypes in PCV13 declined significantly after PCV13 introduction in all ages (P ≤ .01), and the incidence of IPD due to NVTs declined significantly in children aged ≥2 years (P = .003). In 2011–2013, the overall incidences of IPD due to PCV7 serotypes, the 6 additional serotypes in PCV13, and NVTs were 0.3, 2.8, and 4.4 cases/100 000; the incidences among children aged Conclusions. The annual incidence of IPD due to vaccine serotypes (1–3 cases/100 000) among children aged <2 years and nontarget groups demonstrates the success of PCV7 and PCV13. A substantially higher incidence of IPD due to NVTs indicates the importance of ongoing surveillance and extension of vaccine polyvalency.Keywords
This publication has 14 references indexed in Scilit:
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLoS Medicine, 2013
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind TrialClinical Infectious Diseases, 2013
- Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East EnglandEpidemiology and Infection, 2012
- Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate VaccinesThe Journal of Infectious Diseases, 2011
- Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002–2009Epidemiology and Infection, 2011
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyThe Lancet Infectious Diseases, 2011
- Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, EnglandJournal of Medical Microbiology, 2011
- Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype ProjectPLoS Medicine, 2010
- Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, EnglandJournal of Medical Microbiology, 2008
- Invasive Pneumococcal Disease in England and Wales: Vaccination ImplicationsThe Journal of Infectious Diseases, 2001